Results 211 to 220 of about 713,469 (335)

Relapsed Chronic Lymphocytic Leukemia Heralded by Parathyroid Hormone Related Peptide-Mediated Hypercalcemia. [PDF]

Clin Case Rep
Tallavajhala S, Lee J, Dougherty SC, Kurpiel BR, Portell CA.   +4 more
europepmc   +1 more source

Immunodeficiency Diseases and Tumor Immunobiology [PDF]

, 1974
Abramoff, Peter A., Duquesnoy, Rene J.
core   +1 more source

Blood signals: from birth to disease and death

, 2014
Bowman, T., Flores-Figueroa, E., King, K., Kokkaliaris, K., Lessard, J., Trompouki, E., Will, B.   +6 more
core   +1 more source

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy

British Journal of Pharmacology, EarlyView.
Abstract Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear.
Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang
wiley   +1 more source

Exploratory high-throughput screening of repurposed drugs for canine lymphoid malignancies. [PDF]

BMC Vet Res
Nishida M, Sakuma H, Ishida M, Daiku E, Takamiya M, Tomiyasu H, Nakamura S, Tsukamoto A.   +7 more
europepmc   +1 more source

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

New England Journal of Medicine, 2001
B. Druker, C. Sawyers, H. Kantarjian, D. Resta, Sofia Fernandes Reese, J. Ford, R. Capdeville, M. Talpaz   +7 more
semanticscholar   +1 more source

CTCF Is Essential for the Development and Maintenance of CALM‐AF10‐Induced Leukemia

Cancer Science, EarlyView.
CTCF regulates TGM2 gene expression by modulating key histone modifications, including increased acetylation of H3K27 (H3K27ac) and trimethylation of H3K4 (H3K4me3), along with decreased trimethylation of H3K27 (H3K27me3). These epigenetic changes are critical for maintaining the stem‐like properties of CALM‐AF10‐induced AML. Pharmacological inhibition
Yoko Kuroki, Kazutsune Yamagata, Yukiko Aikawa, Yutaka Shima, Hisafumi Shioneri, Issay Kitabayashi   +5 more
wiley   +1 more source

Correction for: Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group. [PDF]

Contemp Oncol (Pozn)
Sośnia O, Iskierka-Jażdżewska E, Puła A, Wiśniewski K, Drozd-Sokołowska J, Morawska M, Gosik U, Woszczyk D, Ogłoza A, Wdowiak K, Paszkiewicz-Kozik E, Wąsik-Szczepanek E, Markiewicz M, Zawartko M, Kokoć A, Szumera-Ciećkiewicz A, Prochorec-Sobieszek M, Jesionek-Kupnicka D, Braun M, Gierej B, Robak T, Lech-Marańda E, Puła B.   +22 more
europepmc   +1 more source

ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation

Cancer Science, EarlyView.
ZNF282 is a zinc finger protein overexpressed in colorectal cancer that facilitates tumor progression by promoting cell cycle progression via E2F1 activation. Our study demonstrates that ZNF282 expression is associated with poor prognosis and may serve as a novel prognostic biomarker and therapeutic target. ABSTRACT Colorectal cancer (CRC) is a leading
Tadashi Abe, Takaaki Masuda, Taro Tobo, Masahiro Hashimoto, Yusuke Nakano, Hideyuki Saito, Takashi Ofuchi, Tomohiko Ikehara, Akinori Tsujimoto, Takafumi Nakano, Katsushi Dairaku, Junichi Takahashi, Kensuke Koike, Koto Kawata, Yuki Ando, Kiyotaka Hosoda, Takanari Tatsumi, Kosuke Hirose, Satoshi Higuchi, Hajime Otsu, Yusuke Yonemura, Ken Eto, Toru Ikegami, Koshi Mimori   +23 more
wiley   +1 more source

Hematological malignancy burden in mainland China and Taiwan from 1990 to 2021 and decadal projections: Insights from the global burden of disease study 2021. [PDF]

PLoS One
Fu Y, Du YZ, Zhang YW, Song F, Gao SJ, Su L.   +5 more
europepmc   +1 more source